NIH-funded research NIH-funded research

Prevention and Intervention Epicenter for CK20-004

Official title: CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter

Funded at J. Craig Venter Institute, INC. · NIH-11549952 · Data updated 2026-11-12

A translational effort from the J. Craig Venter Institute and Cleveland VA to develop and test prevention and intervention strategies for a specific health issue over several years.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJ. Craig Venter Institute, INC.
NIH-funded
Lab location1 site (San Diego, United States)
Project startJune 1, 2021
Project endMay 31, 2027
Funding year2025
Award (this year)$590,489
NIH project number6U54CK000603-05M002
Project IDNIH-11549952 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals at risk or in early stages of the condition targeted by the epicenter program and who are engaged with VA healthcare or associated research sites.

Less likely to help

Patients not connected to the program's sites or not at risk for the targeted condition may see limited or no direct benefit.

What this research studies

This project is a multi-site effort focused on developing practical prevention and intervention approaches. It involves collaboration between a pioneering genomics institute and a veteran affairs medical center to translate scientific ideas into real-world care. The team will work on strategies likely spanning patient education, early detection, and implementing interventions in clinical settings. Participants may contribute samples or data as part of a larger program to improve outcomes for a defined condition.

Why it matters

Potential benefit: If successful, the work could lead to earlier prevention and more effective interventions that improve health outcomes for patients.

How similar studies have gone: Past epicenter or multi-site prevention projects have shown the value of coordinated interventions, though results vary by condition and implementation setting.

Where this research is happening

  • J. Craig Venter Institute, INC.
    San Diego, United States
    Active

Researchers

  • Principal investigator: Fouts, Derrick E — J. Craig Venter Institute, INC.
  • Study coordinator: Fouts, Derrick E

Related research

Other NIH-funded projects on the same topics.

  • ABCD-USA Consortium: Data Analysis, Informatics and Resource Center

    A large U.S. effort to collect and harmonize brain imaging, biospecimens, and survey data from thousands of 9- to 10-year-olds over time to better understand brain development and health.

    NIH research J. Craig Venter Institute, INC. · San Diego, United States · NIH-11613075

  • Lead bacteriophage therapy for tough Klebsiella infections

    Researchers are refining a five-phage mix to treat antibiotic-resistant Klebsiella pneumoniae infections and prepare it for a first-in-human trial.

    NIH research J. Craig Venter Institute, INC. · San Diego, United States · NIH-11384373

  • AI-powered signatures to predict flu severity in diverse patients

    Aging adults and children with flu may get sicker or recover differently, and this project will use artificial intelligence to find patterns across many data types to predict who will have severe illness.

    NIH research J. Craig Venter Institute, INC. · San Diego, United States · NIH-11377192

  • Engineering a virus-based therapy to fight Burkholderia infections

    A scientist team is editing a bacteriophage from Burkholderia to make it a safer, broader-use therapy for people with cystic fibrosis who have Burkholderia infections.

    NIH research J. Craig Venter Institute, INC. · San Diego, United States · NIH-11374693

  • ABCD USA data and resource center for adolescent brain and health

    Collects and shares detailed brain, health, and behavior data from nearly 12,000 U.S. children and teens to help researchers understand adolescent development.

    NIH research J. Craig Venter Institute, INC. · La Jolla, United States · NIH-11304523

  • Investigating a potential treatment target for acute myeloid leukemia

    This study is looking at how a specific protein called JMJD1C affects acute myeloid leukemia (AML) and whether combining treatments that target this protein with drugs that block the RAS pathway can help improve outcomes for patients, especially those with RAS mutations.

    NIH research J. Craig Venter Institute, INC. · La Jolla, United States · NIH-11176820

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.